In this GEN webinar, experts from ChemPartner, Philip Clarke, PhD, Hu Liu, PhD, and Greg Liang, MD, will provide an overview of some of the innovative platforms that are shaping the next-generation of ...

Antibody-Drug Conjugates (ADCs) are a core technology in tumor-targeted therapy, featuring a ‘tripartite integrated design’ of ‘precision carrier-stable linker-potent payload’. The carrier component ...

Antibody-drug conjugates (ADCs) continue to reshape the oncology landscape by combining the target specificity of monoclonal antibodies (mAbs) with the potent cytotoxicity of small-molecule drugs.

If the recent decamping of Peter Obi from the Labour Party to the African Democratic Congress was intended to detonate like a political bombshell, it failed spectacularly. What arrived instead was a ...

TUESDAY, Dec. 30, 2025 (HealthDay News) — While childhood obesity has become more common in recent years, this is a condition that is about more than just weight. Childhood obesity reflects our modern ...

We do spend a lot of time in our own minds, even if we are largely ignoring that whole undercurrent of self-experience. The basic shape, structure, and flow of inner experience often goes unexamined.

Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...

This short comedy sketch takes a thoughtful yet humorous look at serial monogamy and the patterns people fall into in relationships. It explores why thoughts of an ex often linger, not because of the ...

“Everyone thinks they’re on this big journey now,” Debbie said, refilling her glass. “I’ve had it with the journey. I’ve had it with you people.” “I don’t think I’m on a journey,” Burt said.

A new TROP2-targeted ADC showed promising efficacy in an early TNBC trial, with Erika Hamilton, MD, highlighting its potential for broader use in future treatment. “We're hoping that this is a broader ...

Forbes contributors publish independent expert analyses and insights. I write about talent, technology, and the future of work. Organizations spend extraordinary amounts of money on leadership ...